Post by PressRelease on Mar 26, 2024 4:46pm
New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
Comment by
Mork102 on Apr 01, 2024 7:17am
Obviously you haven't been a shareholder for long the announcements of health Canada approval sent the stock to over 30 cents however not a single solitary sale lots of hype from management but never any substance i stopped accumulating last year and refused to be sucked into the PP at 8 cents those that bought at 7 cents last year are not winners
Comment by
lscfa on Apr 01, 2024 9:26am
Obviously you missed the new info.....12 products, not the 5 they have talked about for years.
Comment by
2021Gamble on Apr 01, 2024 9:31am
Well, I certainly hope they have products in the pipeline ... I mean really.... but until they're approved, they are only in the pipeline - so yes, under development ok, that's all good and fine - but unless I really misunderstood things, the other 7 haven't received approval yet, just in the pipeline
Comment by
2021Gamble on Apr 01, 2024 8:03am
That was quite the day in the market actually, the day that was announced - I believe the high on the day was 0.69 or something, so some got a 10 bagger that day - slowly settled since then of course, and there was a PP shortly thereafter open to existing shareholders at 0.15... But here we are... The potential though - so much potential